24 May 2012
HOME
Natural Remedies
"Bacterial/Viral Coinfections";
TLR2 (fungi)Signaling Depletes IRAK1 and Inhibits Induction of Type 1 by TLR7/9 (viruses)-- -CV Harding, 2012 (More in the chart at the bottom of this homepage)
"Multiple Mechanisms of Immune Suppression by B Lymphocytes" (New and Trashes Yale and IDSA)
NIH's Treatment Recommendations for Chronic Active Epstein-Borreliosis, the chronic illness also induced by OspA vaccination or exposure to molds.
ELISA = arbitrary cutoff.
Disclaimer
1998, CIA Oilmen & Israelis plan to overthrow Saddam for the oil.
Bush/Gore Oil/War-(Oct,2000)
Bush's own explainer (Oct
2000) re:
Iraq Oil
GO HERE FOR THE LINKS TO THE OTHER FULL TEXT REPORTS; you need to know
1) what Steere said in 1986 about the testing for Lyme,
2) this (below) Dressler/Steere/Dearborn report, and
3) Steere's "Antigens in Europe" (using bogus high passage G39/40, which is what Steere used here, below)This is the Dressler/Steere/Dearborn Method. I gave it in full text to the FDA vaccine committee (several copies) along with my submission where I demonstrate that this Dearborn Conference took place, and that the older diagnostic standard was different- and it was by Steere, and it reflected Lyme as a Relapsing Fever organism.
It does not meet the FDA rules for a scientifically valid method. (google FDA bioanalytical method validation).
It is more akin to the 7 Ton Elephant Rule as regards antibody (species) detection.
It only detects late Lyme arthritis in a knee as a hypersensitivity reaction- with the high antibody concentration.
Ask yourselves a question: Does the Steere's Lupus form of Lyme conform to this?
Here is the bogus part about high concentration (ROC area) equaling greater accuracy. It does not. This is where Steere claims that high antibody concentration associated with Lyme arthritis is a validation of the method, when we know the specificity of each antibody is the accuracy of the test in a human. If a person has OspA antibody, they have a 100% chance of having Lyme, and the goal in Methods Development and Validations is to validate a method that detects the LOWEST concentration of something, reliably.
These idiots say this Lyme test is "sensitive" when obviously is does not detect LOW concentrations of antibody, if the area of the darkened (absorbance) means MORE AREA EQUALS MORE (higher) CONCENTRATION OF ANTIBODY. This Dressler/Steere article is the exact opposite of the truth! This is a bogus validation and "a bogus article."
